Saturday, February 8, 2014

Comments from Duane Morris LLP to FDA Draft Guidance Re: 503A

Comment from Duane Morris LLP
null
  • See attached file(s)

  • Public Submission
  • Posted:
    02/06/2014
  • ID:
    FDA-2013-D-1444-0028

No comments: